-
Flubendazole (SKU B1759): Reliable Autophagy Modulation in R
2026-05-26
This article provides an evidence-driven guide to using Flubendazole (SKU B1759) for autophagy modulation in cancer biology and neurodegenerative disease research. Drawing on validated protocols and laboratory scenarios, it demonstrates how Flubendazole addresses reproducibility and workflow challenges, supporting rigorous experimental outcomes in cell viability, proliferation, and cytotoxicity assays.
-
IBDV VP3 Protein Drives IRF7 Degradation via Proteasome Path
2026-05-26
This study uncovers how infectious bursal disease virus (IBDV) employs its VP3 protein to target and degrade host IRF7 protein via the ubiquitin-proteasome system, undermining type I interferon responses and facilitating viral replication in chicken cells. These findings clarify a key immune evasion strategy and highlight the proteasome pathway as a potential intervention point for future research.
-
Butylated Hydroxyanisole (BHA): Advancing Translational Redo
2026-05-25
This thought-leadership article unpacks the mechanistic underpinnings and strategic best practices for deploying butylated hydroxyanisole (BHA) in translational research. It bridges oxidative stress biochemistry with high-impact protocol design, referencing both foundational literature and emerging competitive insights, and offers guidance to researchers seeking rigor and reproducibility in ROS and apoptosis signaling studies.
-
ATRX Loss Sensitizes Glioma Cells to RTK and PDGFR Inhibitio
2026-05-25
This study demonstrates that high-grade glioma cells deficient in ATRX are substantially more sensitive to multi-targeted receptor tyrosine kinase (RTK) and platelet-derived growth factor receptor (PDGFR) inhibitors. These findings suggest that ATRX mutation status could serve as a predictive biomarker for optimizing targeted therapy combinations in aggressive gliomas.
-
AICAR Phosphate (Acadesine): Precision Tools for AMPK-Driven
2026-05-24
AICAR phosphate (Acadesine) enables highly selective AMPK activation, making it an indispensable tool for dissecting apoptosis, mitochondrial signaling, and immune modulation in cancer and hypoxia research. This guide delivers practical protocols, troubleshooting advice, and insights from the latest mechanistic studies to elevate experimental reproducibility and impact.
-
Brefeldin A: Applied Protocols for Vesicle Transport and Apo
2026-05-23
Brefeldin A (BFA) is a gold-standard tool for dissecting protein trafficking, ER stress, and apoptosis in cancer and vascular cell models. This guide details stepwise workflows, highlights troubleshooting strategies, and bridges recent biomarker findings to practical assay design—showcasing how APExBIO’s BFA elevates experimental precision.
-
Açaí Extracts: Effects on Hepatocyte Viability and Drug Enzy
2026-05-22
This study systematically assessed various açaí (Euterpe oleracea) extracts for cytotoxicity and their potential to induce drug-metabolizing enzymes and transporters in human hepatocytes. The findings highlight limited induction of key enzymes and transporters, despite dose-dependent cytotoxicity, refining our understanding of botanical-drug interaction risks.
-
3X (DYKDDDDK) Peptide: Transforming FLAG Tag Workflows
2026-05-22
The 3X (DYKDDDDK) Peptide revolutionizes FLAG-based affinity purification and immunodetection with its enhanced sensitivity and compatibility across protein workflows. Recent breakthroughs in membrane biology and structural studies highlight its value for advanced applications, from metal-sensitive ELISA to protein crystallization.
-
SB 202190: Precision p38 MAP Kinase Inhibitor for Research
2026-05-21
SB 202190 sets a benchmark for selective p38 MAP kinase inhibition, enabling researchers to dissect neuroinflammatory, oncogenic, and apoptotic pathways with precision. This article delivers actionable workflows, troubleshooting insights, and real-world applications, leveraging both published evidence and APExBIO’s trusted compound.
-
GDC-0941: Optimizing PI3K Inhibitor Workflows in Cancer Mode
2026-05-21
GDC-0941, a potent and selective PI3K inhibitor from APExBIO, empowers translational cancer research with reproducible, nanomolar-range PI3K/Akt pathway inhibition. This guide distills advanced workflow strategies, protocol parameters, and troubleshooting insights to maximize the impact of GDC-0941 in cell-based and in vivo oncology studies.
-
Overlapping Roles of AP1/FUL-like Genes in Tomato Flowering
2026-05-20
This study elucidates how AP1/FUL-like transcription factors act redundantly to specify reproductive meristem identity and regulate flowering in tomato. By dissecting the contributions of MACROCALYX, FUL2, and MBP20, the research reveals that their combined action is essential for normal floral transition and inflorescence development, offering insights with broad relevance for crop biology.
-
Anti-HMGB1 Rabbit Monoclonal Antibody: Workflow Guide (MA305
2026-05-20
The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) offers targeted, high-affinity detection of HMGB1 protein in human, mouse, and rat samples, supporting Western blot, immunohistochemistry, and flow cytometry protocols. It is suitable for research applications in chromatin protein analysis but is not intended for diagnostic or therapeutic use.
-
Homoharringtonine Rapidly Clears SARS-CoV-2: Mechanistic Evi
2026-05-19
The reference study demonstrates that homoharringtonine, a cytotoxic alkaloid, rapidly eliminates SARS-CoV-2 from the upper respiratory tract in both experimental models and early clinical trials. These findings support homoharringtonine's potential as a first-line antiviral agent and provide mechanistic insights relevant for future coronavirus preparedness.
-
Prostaglandin E2: Mechanisms, Benchmarks, and Research Limit
2026-05-19
Prostaglandin E2 (PGE2) is a potent endogenous autacoid that mediates immune regulation, inflammation, and gastrointestinal mucosal protection via EP receptor subtypes. Its multipotent actions and receptor affinities make it central in inflammation research and translational studies, as documented by APExBIO and recent peer-reviewed literature.
-
Homoharringtonine: Cytotoxic Alkaloid for Cancer & Antiviral
2026-05-18
Homoharringtonine is a cytotoxic alkaloid that inhibits protein synthesis via 80S ribosome binding. It has demonstrated rapid, broad-spectrum antiviral activity against SARS-CoV-2, and is widely used in leukemia and cancer biology research. APExBIO’s formulation (SKU N1504) offers high solubility in ethanol and DMSO, supporting robust cell-based assays.